These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16184028)

  • 1. Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques.
    Ratterree M; Gettie A; Williams V; Malenbaum S; Neurath AR; Cheng-Mayer C; Blanchard J
    AIDS; 2005 Oct; 19(15):1595-9. PubMed ID: 16184028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use.
    Schlievert PM; Strandberg KL; Brosnahan AJ; Peterson ML; Pambuccian SE; Nephew KR; Brunner KG; Schultz-Darken NJ; Haase AT
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4448-54. PubMed ID: 18838587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal distribution of Replens and K-Y Jelly using three imaging techniques.
    Mauck CK; Katz D; Sandefer EP; Nasution MD; Henderson M; Digenis GA; Su I; Page R; Barnhart K
    Contraception; 2008 Mar; 77(3):195-204. PubMed ID: 18279691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
    Boadi T; Schneider E; Chung S; Tsai L; Gettie A; Ratterree M; Blanchard J; Neurath AR; Cheng-Mayer C
    AIDS; 2005 Oct; 19(15):1587-94. PubMed ID: 16184027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial.
    Lacey CJ; Woodhall S; Qi Z; Sawant S; Cowen M; McCormack S; Jiang S
    Int J STD AIDS; 2010 Oct; 21(10):714-7. PubMed ID: 21139151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies.
    Scorpio DG; Ruben DS; Liao Z; Hildreth JE; Fletcher CA
    J Med Primatol; 2008 Feb; 37 Suppl 1():65-73. PubMed ID: 18269532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.
    Manson KH; Wyand MS; Miller C; Neurath AR
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3199-202. PubMed ID: 11036053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.
    Fichorova RN; Zhou F; Ratnam V; Atanassova V; Jiang S; Strick N; Neurath AR
    Antimicrob Agents Chemother; 2005 Jan; 49(1):323-35. PubMed ID: 15616312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.
    Nuttall JP; Thake DC; Lewis MG; Ferkany JW; Romano JW; Mitchnick MA
    Antimicrob Agents Chemother; 2008 Mar; 52(3):909-14. PubMed ID: 18086845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal microbicides: moving ahead after an unexpected setback.
    van de Wijgert JH; Shattock RJ
    AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Trifonova RT; Pasicznyk JM; Fichorova RN
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Vaginal Drug Levels and Safety of a Locally Administered Glycerol Monolaurate Cream in Rhesus Macaques.
    Kirtane AR; Rothenberger MK; Frieberg A; Nephew K; Schultz-Darken N; Schmidt T; Reimann T; Haase AT; Panyam J
    J Pharm Sci; 2017 Jul; 106(7):1821-1827. PubMed ID: 28389267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
    J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of radiolabeled small molecule permeability as a quantitative measure of microbicide candidate toxicity.
    Coleman JS; Fuchs E; Aung WS; Marzinke MA; Bakshi RP; Spiegel HML; Robinson J; Hendrix CW
    Contraception; 2016 Apr; 93(4):331-336. PubMed ID: 26772905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
    Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
    J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
    Malonza IM; Mirembe F; Nakabiito C; Odusoga LO; Osinupebi OA; Hazari K; Chitlange S; Ali MM; Callahan M; Van Damme L
    AIDS; 2005 Dec; 19(18):2157-63. PubMed ID: 16284466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.
    Holt JD; Cameron D; Dias N; Holding J; Muntendam A; Oostebring F; Dreier P; Rohan L; Nuttall J
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3761-70. PubMed ID: 25845860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.
    Catalone BJ; Kish-Catalone TM; Budgeon LR; Neely EB; Ferguson M; Krebs FC; Howett MK; Labib M; Rando R; Wigdahl B
    Antimicrob Agents Chemother; 2004 May; 48(5):1837-47. PubMed ID: 15105142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on anti-HIV vaginal delivery systems development.
    Antimisiaris SG; Mourtas S
    Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.